11 Oct Novo Nordisk Evoke & Evoke + Alzheimer’s Clinical Study
About this study: This study is done to see if the new medicine called semaglutide can help people with early Alzheimer’s disease. This will be done by comparing semaglutide against placebo on the effect on cognition and daily functioning. Who can participate in this study? To be eligible...